TY - JOUR
T1 - The modulation of CA2+ sensitivity regulates contractility of rabbit corpus cavernosum smooth muscle
AU - Takahashi, Ryosuke
AU - Nishimura, Junji
AU - Hirano, Katsuya
AU - Naito, Seiji
AU - Kanaide, Hideo
N1 - Funding Information:
Supported by Grants-in-Aid for Scientific Research 13557067, 13470149, 13832006, 13670723, 13671591, 14657174 and 14570675, and for Scientific Research on Priority Area 14026038) from the Ministry of Education, Culture, Sports, Science and Technology, by Research Grants for Cardiovascular Diseases 12C-2 and 13C-4 from the Ministry of Health, Labour and Welfare, and by grants from the Japan Space Forum, Kanehara Ichiro Memorial Foundation and Mochida Memorial Foundation for Medical and Pharmaceutical Research, Japan.
PY - 2003/6/1
Y1 - 2003/6/1
N2 - Purpose: We examined the role of the modulation of Ca2+ sensitivity for regulating the contractility of corpus cavernosum smooth muscle. Materials and Methods: We applied simultaneous measurements of intracellular Ca2+ concentration and tension in fura-PE3 loaded intact strips and receptor coupled permeabilization by α-toxin. Results: In intact fura-PE3 loaded strips the tension induced by 10 μM. phenylephrine was significantly greater than that produced by depolarization with 118 mM. K+, although the extent of intracellular Ca2+ concentration elevations was similar. During sustained contraction induced by 10 μM. phenylephrine the application of 10 μM. Y-27632 (a Rho kinase inhibitor) induced relaxation with a slight decrease in intracellular Ca2+ concentration, while the application of 3 μM. GF109203X (a protein kinase C inhibitor) induced relaxation without changing intracellular Ca2+ concentration. In α-toxin permeabilized strips 10 μM. phenylephrine induced a larger increase in force at a constant intracellular Ca2+ concentration and produced a leftward shift in the intracellular Ca2+ concentration-tension relationship, a response that was partially inhibited by pretreatment with Y-27632 or GF109203X. Conclusions: These results indicate that in rabbit corpus cavernosum smooth muscle phenylephrine induces contraction not only by increasing intracellular Ca2+ concentration, but also by increasing Ca2+ sensitivity of the contractile apparatus in a Rho kinase and protein kinase C dependent manner. Antagonism of Ca2+ sensitization pathways in the corpus cavernosum smooth muscle represents an alternate target for the treatment of erectile dysfunction.
AB - Purpose: We examined the role of the modulation of Ca2+ sensitivity for regulating the contractility of corpus cavernosum smooth muscle. Materials and Methods: We applied simultaneous measurements of intracellular Ca2+ concentration and tension in fura-PE3 loaded intact strips and receptor coupled permeabilization by α-toxin. Results: In intact fura-PE3 loaded strips the tension induced by 10 μM. phenylephrine was significantly greater than that produced by depolarization with 118 mM. K+, although the extent of intracellular Ca2+ concentration elevations was similar. During sustained contraction induced by 10 μM. phenylephrine the application of 10 μM. Y-27632 (a Rho kinase inhibitor) induced relaxation with a slight decrease in intracellular Ca2+ concentration, while the application of 3 μM. GF109203X (a protein kinase C inhibitor) induced relaxation without changing intracellular Ca2+ concentration. In α-toxin permeabilized strips 10 μM. phenylephrine induced a larger increase in force at a constant intracellular Ca2+ concentration and produced a leftward shift in the intracellular Ca2+ concentration-tension relationship, a response that was partially inhibited by pretreatment with Y-27632 or GF109203X. Conclusions: These results indicate that in rabbit corpus cavernosum smooth muscle phenylephrine induces contraction not only by increasing intracellular Ca2+ concentration, but also by increasing Ca2+ sensitivity of the contractile apparatus in a Rho kinase and protein kinase C dependent manner. Antagonism of Ca2+ sensitization pathways in the corpus cavernosum smooth muscle represents an alternate target for the treatment of erectile dysfunction.
UR - http://www.scopus.com/inward/record.url?scp=0037949057&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037949057&partnerID=8YFLogxK
U2 - 10.1097/01.ju.0000065808.45445.a1
DO - 10.1097/01.ju.0000065808.45445.a1
M3 - Article
C2 - 12771808
AN - SCOPUS:0037949057
SN - 0022-5347
VL - 169
SP - 2412
EP - 2416
JO - Investigative Urology
JF - Investigative Urology
IS - 6
ER -